Altran Technologies: Appointment of a new EVP in charge of Transformation
BUY, Fair Value EUR12 (+17%)
Swiss watches exports declined 1.6% in August
Luxury Goods: Brief Comment
EDF: Lower long-term earnings yet higher short-term potential
BUY, Fair Value EUR21 vs. EUR27,5 (+24%)
Galapagos: What will be Galapagos’s commercial strategy for its proprietary IPF compound?
BUY, Fair Value EUR61 (+5%)
Alten: H1 15 results in line, reiterated positive outlook for H2 15
NEUTRAL, Fair Value EUR44 (0%)
Suez: 2016 EPS up 2.5% following the deal on Sembsita
BUY, Fair Value EUR19 (+17%)
AstraZeneca: Upgrade to BUY on a very favourable risk/reward profile
BUY vs. NEUTRAL, Fair Value 5400p vs. 4830p (+26%)
Korian: Feed back H1: Confident
BUY, Fair Value EUR34 (+5%)
Galapagos: Vertex – timeline only reiterated; Galapagos’ thesis intact
BUY, Fair Value EUR61 (+18%)